Charles Steele Love - Net Worth and Insider Trading

Charles Steele Love Net Worth

The estimated net worth of Charles Steele Love is at least $90 dollars as of 2024-04-26. Charles Steele Love is the VP-Clinical Affairs of Endologix Inc and owns about 4,504 shares of Endologix Inc (ELGXQ) stock worth over $90. Details can be seen in Charles Steele Love's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles Steele Love has not made any transactions after 2016-01-26 and currently still holds the listed stock(s).

Transaction Summary of Charles Steele Love

Charles Steele Love Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles Steele Love owns 1 companies in total, including Endologix Inc (ELGXQ) .

Click here to see the complete history of Charles Steele Love’s form 4 insider trades.

Insider Ownership Summary of Charles Steele Love

Ticker	Comapny	Transaction Date	Type of Owner
ELGXQ	Endologix Inc	2016-01-26	VP-Clinical Affairs

Charles Steele Love Latest Holdings Summary

Charles Steele Love currently owns a total of 1 stock. Charles Steele Love owns 4,504 shares of Endologix Inc (ELGXQ) as of January 26, 2016, with a value of $90.

Latest Holdings of Charles Steele Love

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ELGXQ	Endologix Inc	2016-01-26	4,504	0.02	90

Holding Weightings of Charles Steele Love

Charles Steele Love Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles Steele Love has made a total of 0 transactions in Endologix Inc (ELGXQ) over the past 5 years. The most-recent trade in Endologix Inc is the sale of 428 shares on January 26, 2016, which brought Charles Steele Love around $33,042.

Insider Trading History of Charles Steele Love

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles Steele Love Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Charles Steele Love Ownership Network

Ownership Network List of Charles Steele Love

No Data

Ownership Network Relation of Charles Steele Love

Charles Steele Love Owned Company Details

What does Endologix Inc do?

Who are the key executives at Endologix Inc?

Charles Steele Love is the VP-Clinical Affairs of Endologix Inc. Other key executives at Endologix Inc include director & CEO and Director John Onopchenko , Chief Medical Officer Matthew Thompson , and Controller and Corp Secretary Timothy Nicholas Brady .

Endologix Inc (ELGXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Endologix Inc (ELGXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endologix Inc (ELGXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Endologix Inc (ELGXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Endologix Inc Insider Transactions

No Available Data

Charles Steele Love Mailing Address

Above is the net worth, insider trading, and ownership report for Charles Steele Love. You might contact Charles Steele Love via mailing address: 11 Studebaker Irvine Ca 92618.

Discussions on Charles Steele Love

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.